{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:24:03Z","timestamp":1768991043221,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["FWF P33130"],"award-info":[{"award-number":["FWF P33130"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["W1232"],"award-info":[{"award-number":["W1232"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejphar.2025.178464","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:11:21Z","timestamp":1765987881000},"page":"178464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nezavist (DCUK-OEt) and aminoquinoline analogues interact with the etomidate site and display a complex mode of modulatory action of the GABAA receptor"],"prefix":"10.1016","volume":"1012","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-2626","authenticated-orcid":false,"given":"Xenia","family":"Simeone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3567-8973","authenticated-orcid":false,"given":"Sophia","family":"Khom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika Maria","family":"Doppler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-6577","authenticated-orcid":false,"given":"Thomas","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-6034","authenticated-orcid":false,"given":"Petra","family":"Scholze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Tabakoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-2649","authenticated-orcid":false,"given":"Margot","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2025.178464_bib2","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1038\/s41598-017-05966-x","article-title":"Novel molecule exhibiting selective affinity for GABAA receptor subtypes","volume":"7","author":"Borghese","year":"2017","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.ejphar.2025.178464_bib3","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1073\/pnas.94.20.11031","article-title":"The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid","volume":"94","author":"Belelli","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2025.178464_bib35","unstructured":"Bundesgesetz \u00fcber Versuche an lebenden Tieren (Tierversuchsgesetz 2012 \u2013 TVG 2012) StF: BGBl. I Nr. 114\/2012 (NR: GP XXIV RV 2016 AB 2080 S. 185. BR: 8831 AB 8853 S. 816.) [CELEX-Nr.: 32010L0063]."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178464_bib4","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1038\/s41467-024-49471-y","article-title":"Structural insights into GABAA receptor potentiation by Quaalude","volume":"15","author":"Chojnacka","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.178464_bib5","series-title":"Proceedings of the 3rd International Electronic Conference on Synthetic Organic Chemistry","first-page":"1","article-title":"MarvinSketch and MarvinView: molecule applets for the world wide we","author":"Csizmadia","year":"1999"},{"key":"10.1016\/j.ejphar.2025.178464_bib6","first-page":"93","article-title":"Preclinical efficacy of Nezavist on operant responding for ethanol in dependent rats","volume":"vol. 47","author":"de Guglielmo","year":"2023"},{"issue":"4","key":"10.1016\/j.ejphar.2025.178464_bib7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/ALN.0b013e3181b55fae","article-title":"Gamma-amino butyric acid type A receptor mutations at beta2N265 alter etomidate efficacy while preserving basal and agonist-dependent activity","volume":"111","author":"Desai","year":"2009","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.ejphar.2025.178464_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0896-6273(90)90337-F","article-title":"Functional and molecular distinction between recombinant rat GABAA receptor subtypes by Zn2+","volume":"5","author":"Draguhn","year":"1990","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.ejphar.2025.178464_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","article-title":"An emerging circuit pharmacology of GABAA receptors","volume":"39","author":"Engin","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2025.178464_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/ALN.0b013e3181ff72b5","article-title":"Clinical and molecular pharmacology of etomidate","volume":"114","author":"Forman","year":"2011","journal-title":"Anesthesiology"},{"issue":"Pt 3","key":"10.1016\/j.ejphar.2025.178464_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1469-7793.1998.609bv.x","article-title":"Zn2+ inhibition of recombinant GABAA receptors: an allosteric, state-dependent mechanism determined by the gamma-subunit","volume":"506","author":"Gingrich","year":"1998","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2025.178464_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2019.07.008","article-title":"Variations on a scaffold - novel GABAA receptor modulators","volume":"180","author":"Iorio","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"7824","key":"10.1016\/j.ejphar.2025.178464_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2654-5","article-title":"Shared structural mechanisms of general anaesthetics and benzodiazepines","volume":"585","author":"Kim","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178464_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13321-016-0139-1","article-title":"AutoDock VinaXB: implementation of XBSF, new empirical halogen bond scoring function, into AutoDock Vina","volume":"8","author":"Koebel","year":"2016","journal-title":"J. Cheminf."},{"issue":"22","key":"10.1016\/j.ejphar.2025.178464_bib15","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1111\/bph.13329","article-title":"Identification of the putative binding pocket of valerenic acid on GABAA receptors using docking studies and site-directed mutagenesis","volume":"172","author":"Luger","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"7740","key":"10.1016\/j.ejphar.2025.178464_bib16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","article-title":"GABAA receptor signalling mechanisms revealed by structural pharmacology","volume":"565","author":"Masiulis","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejphar.2025.178464_bib17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1523\/JNEUROSCI.5012-10.2011","article-title":"The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs","volume":"31","author":"Ramerstorfer","year":"2011","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.ejphar.2025.178464_bib18","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1523\/JNEUROSCI.23-24-08608.2003","article-title":"Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms","volume":"23","author":"Reynolds","year":"2003","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.ejphar.2025.178464_bib19","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0028-3908(96)00138-4","article-title":"Direct activation of GABAA receptors by loreclezole, an anticonvulsant drug with selectivity for the beta-subunit","volume":"35","author":"Sanna","year":"1996","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.ejphar.2025.178464_bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0026-895X(24)13490-6","article-title":"Differential subunit dependence of the actions of the general anesthetics alphaxalone and etomidate at gamma-aminobutyric acid type A receptors expressed in Xenopus laevis oocytes","volume":"51","author":"Sanna","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2025.178464_bib21","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/acsptsci.0c00111","article-title":"Allosteric modulation of GABAA receptors in Rat Basolateral Amygdala blocks stress-enhanced reacquisition of nicotine self-administration","volume":"3","author":"Sharp","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"17","key":"10.1016\/j.ejphar.2025.178464_bib22","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1021\/acs.jcim.3c00563","article-title":"High-quality conformer generation with CONFORGE: algorithm and performance assessment","volume":"63","author":"Seidel","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.ejphar.2025.178464_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1476-5381.2011.01779.x","article-title":"A novel GABA(A) receptor pharmacology: drugs interacting with the \u03b1(+) \u03b2(-) interface","volume":"166","author":"Sieghart","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178464_bib24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International union of basic and clinical pharmacology. CVI: GABAA receptor Subtype- and function-selective ligands: key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178464_bib33","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1038\/s41598-017-05757-4","article-title":"Molecular tools for GABA(A) receptors: High affinity ligands for beta1-containing subtypes","volume":"7","author":"Simeone","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178464_bib34","doi-asserted-by":"crossref","first-page":"114780","DOI":"10.1016\/j.ejmech.2022.114780","article-title":"Novel alpha6 preferring GABA-A receptor ligands based on loreclezole","volume":"244","author":"Simeone","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejphar.2025.178464_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111470","article-title":"Mutations at beta N265 in \u03b3-aminobutyric acid type A receptors alter both binding affinity and efficacy of potent anesthetics","volume":"9","author":"Stewart","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.178464_bib26","unstructured":"Tabakoff B. Multifunctional aminoquinoline therapeutic agent. Patent. No.: US 10,435,371 B2. Lohocla research corporation, Evanston IL (US). Date of Patent: October. 8, 2019."},{"key":"10.1016\/j.ejphar.2025.178464_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pbb.2013.10.009","article-title":"The neurobiology of alcohol consumption and alcoholism: an integrative history","volume":"113","author":"Tabakoff","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178464_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00424-006-0183-1","article-title":"Optimized expression vector for ion channel studies in Xenopus oocytes and mammalian cells using alfalfa mosaic virus","volume":"454","author":"Venkatachalan","year":"2007","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"4","key":"10.1016\/j.ejphar.2025.178464_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0896-6273(94)90330-1","article-title":"A novel allosteric modulatory site on the GABAA receptor beta subunit","volume":"12","author":"Wafford","year":"1994","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.ejphar.2025.178464_bib30","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1073\/pnas.91.10.4569","article-title":"The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit","volume":"91","author":"Wingrove","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178464_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ejphar.2025.178464_bib32","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1038\/s41467-022-32212-4","article-title":"Structural and dynamic mechanisms of GABAA receptor modulators with opposing activities","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992501218X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992501218X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T20:37:54Z","timestamp":1768941474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992501218X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"alternative-id":["S001429992501218X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178464","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nezavist (DCUK-OEt) and aminoquinoline analogues interact with the etomidate site and display a complex mode of modulatory action of the GABAA receptor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178464"}}